Albert B. DeLeo

Massachusetts General Hospital — United States

Immunology and Microbiology · Life Sciences

48h-index9.3kcitations201works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(109), Cancer Immunotherapy and Biomarkers(55), Cancer Research and Treatments(45), RNA Interference and Gene Delivery(33), Virus-based gene therapy research(26)

Publications201 total

Correction: Improving the therapeutic efficacy of sorafenib for hepatocellular carcinoma by repurposing disulfiram
Frontiers in Oncology·2026Open Access
Characterization and Functional Significance of NKR-P1 (3.2.3 Antigen): A Novel Triggering Molecule
2024
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment
Nature Communications·2023· 38 citedOpen Access
Supplementary Figure 3 from Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice
2023Open Access
Supplementary Figure 2 from Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice
2023Open Access
Supplementary Figure 2 from Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice
2023Open Access
Supplementary Figure 1 from Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice
2023Open Access
Data from Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice
2023Open Access
Supplementary Figure 1 from Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice
2023Open Access
Supplementary Figure 4 from Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice
2023Open Access
Supplementary Figure 4 from Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice
2023Open Access
Data from Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice
2023Open Access
Supplementary Figure 3 from Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice
2023Open Access
Supplementary Figure 2 from Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer
2023Open Access
Supplementary Table 3 from Targeting ALDH<sup>bright</sup> Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8<sup>+</sup> T Cells
2023Open Access
Supplementary Figure 1 from Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer
2023Open Access
Supplementary Figure 1 from Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck Cancer
2023Open Access
Supplementary Table 1 from Targeting ALDH<sup>bright</sup> Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8<sup>+</sup> T Cells
2023Open Access
Supplementary Figure 3a from Targeting ALDH<sup>bright</sup> Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8<sup>+</sup> T Cells
2023Open Access
Supplementary Figure 2 from Targeting ALDH<sup>bright</sup> Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8<sup>+</sup> T Cells
2023Open Access
page 1 of 11Next →

Frequent Co-authors

Theresa L. Whiteside(15), Lloyd J. Old(9), Soldano Ferrone(9), Walter J. Storkus(8), Ettore Appella(8), Xinhui Wang(6), Michael T. Lotze(5), Carmen Visús(5), Robert L. Ferris(5), Kazuaki Chikamatsu(5), José Mayordomo(4), William E. Gooding(4), Thomas Tüting(4), Thomas K. Hoffmann(4), Laurence Zitvogel(3), Gregory D. Jay(3), Andreas E. Albers(3), Vera S. Donnenberg(3), Koji Nakano(3), Andrea Gambotto(3)